Compositions for preventing and treating infection
Compositions for preventing and treating infection
Composition including saccharin in an amount sufficient to inhibit bacterial growth and/or virulence for use in a method of treating and/or preventing infection, wherein the composition is formulated for application to a patient’s skin, wherein the composition is formulated for inhalation, or wherein the composition is formulated for intravenous administration. Preferably, the infection is caused by Pseudomonas aeruginosa, Acinetobacter baumannii, Enterococcus faecalis, Klebsiella pneumoniae, Stenotrophomonas maltophilia or Enterobacter. Bacterial mobility and biofilm formation may be inhibited. The saccharin may be sodium saccharin. Composition may be formulated for administration to a patients skin and/or application to a wound. Composition may be a liquid, cream, ointment, gel or hydrogel and/or may be incorporated into a wound dressing. Formulated for inhalation may result in an aerosolised or dry powder composition.
GB2627150
Intellectual Property Office
14 August 2024
Ronan, McCarthy
0b2cf2e0-b0ff-4c92-aa04-92d91182d1f2
Ronan, McCarthy
(Inventors)
(2024)
Compositions for preventing and treating infection.
GB2627150.
Abstract
Composition including saccharin in an amount sufficient to inhibit bacterial growth and/or virulence for use in a method of treating and/or preventing infection, wherein the composition is formulated for application to a patient’s skin, wherein the composition is formulated for inhalation, or wherein the composition is formulated for intravenous administration. Preferably, the infection is caused by Pseudomonas aeruginosa, Acinetobacter baumannii, Enterococcus faecalis, Klebsiella pneumoniae, Stenotrophomonas maltophilia or Enterobacter. Bacterial mobility and biofilm formation may be inhibited. The saccharin may be sodium saccharin. Composition may be formulated for administration to a patients skin and/or application to a wound. Composition may be a liquid, cream, ointment, gel or hydrogel and/or may be incorporated into a wound dressing. Formulated for inhalation may result in an aerosolised or dry powder composition.
This record has no associated files available for download.
More information
Published date: 14 August 2024
Identifiers
Local EPrints ID: 508328
URI: http://eprints.soton.ac.uk/id/eprint/508328
PURE UUID: 787821d1-23e5-421d-a6f9-07e0f9261735
Catalogue record
Date deposited: 19 Jan 2026 17:32
Last modified: 20 Jan 2026 03:14
Export record
Contributors
Inventor:
McCarthy Ronan
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics